Synthesis of Ibuprofen Monoglyceride Using Novozym®435: Biocatalyst Activation and Stabilization in Multiphasic Systems

dc.contributor.authorRavelo Velasquez, Marianela
dc.contributor.authorGallardo, M.Esther
dc.contributor.authorLadero Galán, Miguel
dc.contributor.authorGarcía-Ochoa Soria, Félix
dc.date.accessioned2023-06-22T11:10:32Z
dc.date.available2023-06-22T11:10:32Z
dc.date.issued2022
dc.description.abstractThis work was focused on the enzymatic esterification of glycerol and ibuprofen at high concentrations in two triphasic systems composed of toluene+ibuprofene (apolar) and glycerol or glycerol–water (polar) liquid phases, and a solid phase with the industrial immobilized lipase B from Candida antarctica named Novozym®435 (N435) acting as the biocatalyst. Based on a preliminary study, the concentration of the enzyme was set at 30 g·L−1 and the stirring speed at 720 r.p.m to reduce external mass transfer limitations. To obtain more information on the reaction system, it was conducted at a wide range of temperatures (50 to 80 °C) and initial concentrations of ibuprofen (20–100 g·L−1, that is, 97 to 483 mM). Under these experimental conditions, the external mass transfer, according to the Mears criterion (Me = 1.47–3.33·10−4 << 0.15), was fast, presenting no limitation to the system productivity, regardless of the presence of water and from 50 to 80 °C. Considering that the enzyme is immobilized in a porous ion-exchange resin, limitations due to internal mass transfer can exist, depending on the values of the effectiveness factor (η). It varied from 0.14 to 0.23 at 50 to 80 °C and 0.32–1 mm particle diameter range in the absence of water, and in the same ranges, from 0.40 to 0.66 in the presence of 7.4% w/w water in the glycerol phase. Thus, it is evident that some limitation occurs due to mass transfer inside the pores, while the presence of water in the polar phase increases the productivity 3–4 fold. During the kinetic study, several kinetic models were proposed for both triphasic reacting systems, with and without first-order biocatalyst deactivation, and their fit to all relevant experimental data led to the observation that the best kinetic model was a reversible hyperbolic model with first-order deactivation in the anhydrous reaction system and a similar model, but without deactivation, for the system with added water at zero time. This fact is in sharp contrast to the use of N435 in a water-glycerol monophasic system, where progressive dissolution of ibuprofen in the reacting media, together with a notable enzyme deactivation, is observed.
dc.description.departmentDepto. de Ingeniería Química y de Materiales
dc.description.facultyFac. de Ciencias Químicas
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Ciencia, Innovación
dc.description.sponsorshipInstituto de Salud Carlos III (ISCIII)
dc.description.sponsorshipUnión Europea
dc.description.statuspub
dc.eprint.idhttps://eprints.ucm.es/id/eprint/78088
dc.identifier.doi10.3390/catal12121531
dc.identifier.issn2073-4344
dc.identifier.officialurlhttps://doi.org/10.3390/catal12121531
dc.identifier.urihttps://hdl.handle.net/20.500.14352/72178
dc.journal.titleCatalysts
dc.language.isoeng
dc.publisherMDPI
dc.relation.projectIDCTQ 2010-15460, CTQ2011-12725-E, CTQ2017-84963-C2-1-R and PID2020-114365RB-C21
dc.relation.projectIDPI15/00484, CP16/00046 and PI18/00151
dc.relation.projectIDPI21/00162 and CPII21/00011
dc.rightsAtribución 3.0 España
dc.rights.accessRightsopen access
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/es/
dc.subject.cdu66.0
dc.subject.keywordibuprofen
dc.subject.keywordmonoglyceride
dc.subject.keywordtoluene
dc.subject.keywordbiphasic system
dc.subject.keywordNovozym®435
dc.subject.keywordester prodrug
dc.subject.ucmIngeniería química
dc.subject.unesco3303 Ingeniería y Tecnología Químicas
dc.titleSynthesis of Ibuprofen Monoglyceride Using Novozym®435: Biocatalyst Activation and Stabilization in Multiphasic Systems
dc.typejournal article
dc.volume.number12
dspace.entity.typePublication
relation.isAuthorOfPublication24473ce5-8582-4e7e-b28a-cd5f91d1aeab
relation.isAuthorOfPublication9633a9e2-bbb6-4ca6-9f86-4b91f3739111
relation.isAuthorOfPublication.latestForDiscovery24473ce5-8582-4e7e-b28a-cd5f91d1aeab

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
catalysts-12-01531-v2.pdf
Size:
2.4 MB
Format:
Adobe Portable Document Format

Collections